{
  "name": "Michael Zoratti",
  "first_name": "Michael",
  "last_name": "Zoratti",
  "middle_names": "",
  "title": "Assistant Professor (Part-Time), Health Research Methods, Evidence, and Impact",
  "photo_url": "https://experts.mcmaster.ca/harvestedImages/fullImages/8754.jpg",
  "email": "zorattmj@mcmaster.ca",
  "websites": [],
  "linkedin": "",
  "twitter": "",
  "websites_json": "[]",
  "primary_website": "",
  "overview": "",
  "affiliations_json": "[{\"organizations\": \"Faculty of Health Sciences > McMaster University\"}, {\"position\": \"Assistant Professor (Part-Time)\", \"organizations\": \"Health Research Methods, Evidence, and Impact > Faculty of Health Sciences\"}]",
  "all_affiliations": "Faculty of Health Sciences > McMaster University ; Assistant Professor (Part-Time), Health Research Methods, Evidence, and Impact > Faculty of Health Sciences",
  "all_organizations": "Faculty of Health Sciences > McMaster University ; Health Research Methods, Evidence, and Impact > Faculty of Health Sciences",
  "primary_affiliation": "Faculty of Health Sciences > McMaster University",
  "primary_position": "",
  "research_areas": "",
  "research_areas_json": "[]",
  "education_json": "[{\"degree\": \"Ph.D\", \"institution\": \"McMaster University2022\"}, {\"degree\": \"M.Sc\", \"institution\": \"McMaster University2014\"}]",
  "all_degrees": "Ph.D, McMaster University2022 ; M.Sc, McMaster University2014",
  "all_degrees_only": "Ph.D ; M.Sc",
  "all_institutions": "McMaster University2022 ; McMaster University2014",
  "highest_degree": "Ph.D",
  "degree_institution": "McMaster University2022",
  "total_publications": 67,
  "journal_articles_count": 55,
  "book_chapters_count": 0,
  "conference_papers_count": 8,
  "recent_publications_count": 39,
  "publications_json": "{\"journal_articles\": [{\"title\": \"Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel.\", \"url\": \"https://experts.mcmaster.ca/display/publication3534474\", \"journal\": \"Blood Advances\", \"year\": \"2025\", \"doi\": \"10.1182/bloodadvances.2024013656\"}, {\"title\": \"Abstract 4991: Temporal trends in health-related quality of life (HRQoL) outcomes in fourth line or higher treatment for relapsed/refractory multiple myeloma (RRMM): A systematic literature review (SLR) and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3587043\", \"journal\": \"Cancer Research\", \"year\": \"2025\", \"doi\": \"10.1158/1538-7445.am2025-4991\"}, {\"title\": \"Health Related Quality of Life (HRQoL) in Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review (SLR) and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3505084\", \"journal\": \"Blood\", \"year\": \"2024\", \"doi\": \"10.1182/blood-2024-203741\"}, {\"title\": \"Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3450503\", \"journal\": \"Leukemia and Lymphoma\", \"year\": \"2024\", \"doi\": \"10.1080/10428194.2024.2369653\"}, {\"title\": \"MM-357 Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients\", \"url\": \"https://experts.mcmaster.ca/display/publication3494186\", \"journal\": \"Clinical Lymphoma, Myeloma and Leukemia\", \"year\": \"2024\", \"doi\": \"10.1016/s2152-2650(24)01670-7\"}, {\"title\": \"P-063 Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients\", \"url\": \"https://experts.mcmaster.ca/display/publication3494184\", \"journal\": \"Clinical Lymphoma, Myeloma and Leukemia\", \"year\": \"2024\", \"doi\": \"10.1016/s2152-2650(24)01966-9\"}, {\"title\": \"Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients\", \"url\": \"https://experts.mcmaster.ca/display/publication3494185\", \"journal\": \"Clinical Lymphoma, Myeloma and Leukemia\", \"year\": \"2024\", \"doi\": \"10.1016/s2152-2650(24)00957-1\"}, {\"title\": \"Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials\", \"url\": \"https://experts.mcmaster.ca/display/publication3385438\", \"journal\": \"BMJ Open\", \"year\": \"2024\", \"doi\": \"10.1136/bmjopen-2022-068182\"}, {\"title\": \"Cystoid macular edema prophylaxis in cataract surgery: A protocol for network meta-analysis.\", \"url\": \"https://experts.mcmaster.ca/display/publication3504795\", \"journal\": \"PLoS ONE\", \"year\": \"2024\", \"doi\": \"10.1371/journal.pone.0314467\"}, {\"title\": \"EE688 Case for Clear Communication and Justification of Survival Extrapolation Methodology: A Review of NICE Submissions in Oncology\", \"url\": \"https://experts.mcmaster.ca/display/publication3494187\", \"journal\": \"Value in Health\", \"year\": \"2023\", \"doi\": \"10.1016/j.jval.2023.09.953\"}, {\"title\": \"MSR15 The Impact of Response Assessment Timing on Indirect Treatment Comparisons (ITCS) \\u2013 A Simulation Study\", \"url\": \"https://experts.mcmaster.ca/display/publication3494188\", \"journal\": \"Value in Health\", \"year\": \"2023\", \"doi\": \"10.1016/j.jval.2023.09.2074\"}, {\"title\": \"MCL-373 Unmet Need in Relapsed/Refractory (RR) Mantle Cell Lymphoma (MCL) Post-Bruton Tyrosine Kinase Inhibitor (BTKi): Systematic Literature Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3494190\", \"journal\": \"Clinical Lymphoma, Myeloma and Leukemia\", \"year\": \"2023\", \"doi\": \"10.1016/s2152-2650(23)01377-0\"}, {\"title\": \"POSTER: MCL-373 Unmet Need in Relapsed/Refractory (RR) Mantle Cell Lymphoma (MCL) Post-Bruton Tyrosine Kinase Inhibitor (BTKi): Systematic Literature Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3494189\", \"journal\": \"Clinical Lymphoma, Myeloma and Leukemia\", \"year\": \"2023\", \"doi\": \"10.1016/s2152-2650(23)00776-0\"}, {\"title\": \"Theory and practice of Bayesian and frequentist frameworks for network meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2315252\", \"journal\": \"BMJ Evidence-Based Medicine\", \"year\": \"2023\", \"doi\": \"10.1136/bmjebm-2022-111928\"}, {\"title\": \"UNMET NEED IN RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) POST\\u2010BRUTON TYROSINE KINASE INHIBITOR (BTKI): A SYSTEMATIC LITERATURE REVIEW AND META\\u2010ANALYSIS\", \"url\": \"https://experts.mcmaster.ca/display/publication3494192\", \"journal\": \"Hematological Oncology\", \"year\": \"2023\", \"doi\": \"10.1002/hon.3165_603\"}, {\"title\": \"Treatment outcomes for newly diagnosed, treatment-na\\u00efve TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2980732\", \"journal\": \"Journal of Hematology and Oncology\", \"year\": \"2023\", \"doi\": \"10.1186/s13045-023-01417-5\"}, {\"title\": \"Azacitidine Monotherapy in Patients With Treatment-Na\\u00efve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2658796\", \"journal\": \"Clinical Lymphoma, Myeloma and Leukemia\", \"year\": \"2023\", \"doi\": \"10.1016/j.clml.2022.11.002\"}, {\"title\": \"Reverse Total Shoulder Arthroplasty Is the Most Cost-effective Treatment Strategy for Proximal Humerus Fractures in Older Adults: A Cost-utility Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication2433833\", \"journal\": \"Clinical Orthopaedics and Related Research\", \"year\": \"2022\", \"doi\": \"10.1097/corr.0000000000002219\"}, {\"title\": \"Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-na\\u00efve, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.\", \"url\": \"https://experts.mcmaster.ca/display/publication3245942\", \"journal\": \"Journal of Clinical Oncology\", \"year\": \"2022\", \"doi\": \"10.1200/jco.2022.40.16_suppl.e19062\"}, {\"title\": \"Treatment outcomes for newly diagnosed, untreatedTP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.\", \"url\": \"https://experts.mcmaster.ca/display/publication3245943\", \"journal\": \"Journal of Clinical Oncology\", \"year\": \"2022\", \"doi\": \"10.1200/jco.2022.40.16_suppl.e19020\"}, {\"title\": \"POSC427 Platform Trials: A Path to Efficient Decision Making and Faster Drug Approvals for Health Technology Assessment Bodies\", \"url\": \"https://experts.mcmaster.ca/display/publication3245944\", \"journal\": \"Value in Health\", \"year\": \"2022\", \"doi\": \"10.1016/j.jval.2021.11.1346\"}, {\"title\": \"Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART\", \"url\": \"https://experts.mcmaster.ca/display/publication1965105\", \"journal\": \"BMC Medical Research Methodology\", \"year\": \"2021\", \"doi\": \"10.1186/s12874-021-01254-5\"}, {\"title\": \"Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)\", \"url\": \"https://experts.mcmaster.ca/display/publication1983995\", \"journal\": \"PharmacoEconomics (Auckland)\", \"year\": \"2021\", \"doi\": \"10.1007/s40273-021-01039-0\"}, {\"title\": \"Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists\", \"url\": \"https://experts.mcmaster.ca/display/publication1966330\", \"journal\": \"European Journal of Health Economics\", \"year\": \"2021\", \"doi\": \"10.1007/s10198-021-01286-0\"}, {\"title\": \"Clinical Trial Data Sharing for COVID-19\\u2013Related Research\", \"url\": \"https://experts.mcmaster.ca/display/publication1963558\", \"journal\": \"Journal of Medical Internet Research\", \"year\": \"2021\", \"doi\": \"10.2196/26718\"}, {\"title\": \"Heterogeneity in renal end\\u00a0points of cardiovascular outcomes trials in Type 2 diabetes\", \"url\": \"https://experts.mcmaster.ca/display/publication2658699\", \"journal\": \"Journal of Comparative Effectiveness Research\", \"year\": \"2021\", \"doi\": \"10.2217/cer-2020-0137\"}, {\"title\": \"Reporting and design of randomized controlled trials for COVID-19: A systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication1940270\", \"journal\": \"Contemporary Clinical Trials\", \"year\": \"2021\", \"doi\": \"10.1016/j.cct.2020.106239\"}, {\"title\": \"Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents\", \"url\": \"https://experts.mcmaster.ca/display/publication1941464\", \"journal\": \"Journal of the Endocrine Society\", \"year\": \"2021\", \"doi\": \"10.1210/jendso/bvaa155\"}, {\"title\": \"Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1939396\", \"journal\": \"EClinicalMedicine\", \"year\": \"2020\", \"doi\": \"10.1016/j.eclinm.2020.100573\"}, {\"title\": \"Conservative Intervention Strategies for Adult Cancer-Related Lymphedema: A Systematic Review and Network Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1923169\", \"journal\": \"Oncology Nursing Forum\", \"year\": \"2020\", \"doi\": \"10.1188/20.onf.e171-e189\"}, {\"title\": \"PNS18 IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT)\", \"url\": \"https://experts.mcmaster.ca/display/publication2579408\", \"journal\": \"Value in Health\", \"year\": \"2020\", \"doi\": \"10.1016/j.jval.2020.04.1029\"}, {\"title\": \"An Exploratory Analysis of Predictors of Concordance Between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta\", \"url\": \"https://experts.mcmaster.ca/display/publication1698147\", \"journal\": \"Healthcare Policy\", \"year\": \"2020\", \"doi\": \"10.12927/hcpol.2020.26128\"}, {\"title\": \"Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1688096\", \"journal\": \"EClinicalMedicine\", \"year\": \"2020\", \"doi\": \"10.1016/j.eclinm.2019.12.007\"}, {\"title\": \"The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries\", \"url\": \"https://experts.mcmaster.ca/display/publication1943576\", \"journal\": \"Infection and Drug Resistance\", \"year\": \"2020\", \"doi\": \"10.2147/idr.s288399\"}, {\"title\": \"Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols\", \"url\": \"https://experts.mcmaster.ca/display/publication1665447\", \"journal\": \"Trials\", \"year\": \"2019\", \"doi\": \"10.1186/s13063-019-3664-1\"}, {\"title\": \"PDB3 HETEROGENEITY IN RENAL COMPOSITE ENDPOINTS IN CARDIOVASCULAR OUTCOMES TRIALS IN TYPE 2 DIABETES (T2D)\", \"url\": \"https://experts.mcmaster.ca/display/publication3245950\", \"journal\": \"Value in Health\", \"year\": \"2019\", \"doi\": \"10.1016/j.jval.2019.09.885\"}, {\"title\": \"PNS278 A REVIEW OF HEALTH TECHNOLOGY ASSESSMENT GUIDELINES ON THE APPROVAL OF BIOSIMILARS\", \"url\": \"https://experts.mcmaster.ca/display/publication3245951\", \"journal\": \"Value in Health\", \"year\": \"2019\", \"doi\": \"10.1016/j.jval.2019.09.2178\"}, {\"title\": \"Reporting of master protocols towards a standardized approach: A systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication1654087\", \"journal\": \"Contemporary Clinical Trials Communications\", \"year\": \"2019\", \"doi\": \"10.1016/j.conctc.2019.100406\"}, {\"title\": \"A Profile of Older Adults With a History of Stroke Receiving Home Care in Ontario, Canada\", \"url\": \"https://experts.mcmaster.ca/display/publication1697803\", \"journal\": \"Home Health Care Management and Practice\", \"year\": \"2019\", \"doi\": \"10.1177/1084822318823731\"}, {\"title\": \"Health Utility Book (HUB)\\u2013Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer\", \"url\": \"https://experts.mcmaster.ca/display/publication1663230\", \"journal\": \"MDM Policy and Practice\", \"year\": \"2019\", \"doi\": \"10.1177/2381468319852594\"}, {\"title\": \"Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy\", \"url\": \"https://experts.mcmaster.ca/display/publication3245952\", \"journal\": \"Clinical Research in Cardiology\", \"year\": \"2019\", \"doi\": \"10.1007/s00392-018-1379-z\"}, {\"title\": \"Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)\", \"url\": \"https://experts.mcmaster.ca/display/publication1634805\", \"journal\": \"Medical decision making\", \"year\": \"2019\", \"doi\": \"10.1177/0272989x19837969\"}, {\"title\": \"How do financial (dis)incentives influence health behaviour and costs? Protocol for a systematic literature review of randomised controlled trials\", \"url\": \"https://experts.mcmaster.ca/display/publication1639835\", \"journal\": \"BMJ Open\", \"year\": \"2019\", \"doi\": \"10.1136/bmjopen-2018-024694\"}, {\"title\": \"Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma\", \"url\": \"https://experts.mcmaster.ca/display/publication1630075\", \"journal\": \"Cancer Treatment Reviews\", \"year\": \"2019\", \"doi\": \"10.1016/j.ctrv.2019.02.001\"}, {\"title\": \"Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1936699\", \"journal\": \"Gates Open Research\", \"year\": \"2019\", \"doi\": \"10.12688/gatesopenres.13081.2\"}, {\"title\": \"Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1545901\", \"journal\": \"Schizophrenia Research and Treatment\", \"year\": \"2018\", \"doi\": \"10.1155/2018/1543034\"}, {\"title\": \"Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey\", \"url\": \"https://experts.mcmaster.ca/display/publication829123\", \"journal\": \"Journal of Clinical Epidemiology\", \"year\": \"2017\", \"doi\": \"10.1016/j.jclinepi.2017.06.004\"}, {\"title\": \"Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3245953\", \"journal\": \"Diabetes Therapy\", \"year\": \"2017\", \"doi\": \"10.1007/s13300-016-0217-4\"}, {\"title\": \"Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review\", \"url\": \"https://experts.mcmaster.ca/display/publication794752\", \"journal\": \"BMC Pediatrics\", \"year\": \"2016\", \"doi\": \"10.1186/s12887-016-0710-y\"}, {\"title\": \"What Is the Link Between Corporal Punishment and Child Physical Abuse?\", \"url\": \"https://experts.mcmaster.ca/display/publication2658700\", \"journal\": \"Journal of Family Violence\", \"year\": \"2015\", \"doi\": \"10.1007/s10896-014-9663-9\"}, {\"title\": \"Highlights of the Canadian Frailty Network (CFN) Highly Qualified Personnel Poster Session\", \"url\": \"https://experts.mcmaster.ca/display/publication1972012\", \"journal\": \"Canadian Geriatrics Journal\", \"doi\": \"10.57700/cgj.22.369\"}, {\"title\": \"Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication3245945\", \"journal\": \"Gates Open Research\", \"doi\": \"10.12688/gatesopenres.13081.1\"}, {\"title\": \"P1204: AXICABTAGENE CILOLEUCEL VEIN\\u2010TO\\u2010VEIN TIME IN TRIAL OR REAL\\u2010WORLD SETTINGS VS OTHER CAR T\\u2010CELL THERAPIES FOR RELAPSED/REFRACTORY LARGE B\\u2010CELL LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW AND META\\u2010ANALYSIS\", \"url\": \"https://experts.mcmaster.ca/display/publication3494191\", \"journal\": \"HemaSphere\", \"doi\": \"10.1097/01.hs9.0000971712.73401.70\"}, {\"title\": \"P552: TREATMENT OUTCOMES IN NEWLY DIAGNOSED, UNTREATED PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS\", \"url\": \"https://experts.mcmaster.ca/display/publication3245941\", \"journal\": \"HemaSphere\", \"doi\": \"10.1097/01.hs9.0000845096.01949.78\"}, {\"title\": \"P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHERAPY FOR TREATMENT-NAIVE PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS\", \"url\": \"https://experts.mcmaster.ca/display/publication3245940\", \"journal\": \"HemaSphere\", \"doi\": \"10.1097/01.hs9.0000845980.88839.7d\"}], \"chapters\": [], \"conferences\": [{\"title\": \"Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naive, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.\", \"url\": \"https://experts.mcmaster.ca/display/publication2472487\", \"journal\": \"Journal of Clinical Oncology\", \"year\": \"2022\"}, {\"title\": \"Treatment outcomes for newly diagnosed, untreatedTP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.\", \"url\": \"https://experts.mcmaster.ca/display/publication2472488\", \"journal\": \"Journal of Clinical Oncology\", \"year\": \"2022\"}, {\"title\": \"IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT)\", \"url\": \"https://experts.mcmaster.ca/display/publication1914423\", \"journal\": \"Value in Health\", \"year\": \"2020\"}, {\"title\": \"PCN41 THE HEALTH UTILITY BOOK (HUB): A REGISTRY OF HEALTH STATE UTILITY VALUES IN ONCOLOGY\", \"url\": \"https://experts.mcmaster.ca/display/publication1658797\", \"journal\": \"Value in Health\", \"year\": \"2019\", \"doi\": \"10.1016/j.jval.2019.04.165\"}, {\"title\": \"PCN42 THE HEALTH UTILITY BOOK (HUB): TOWARD A CENTRALIZED, SYSTEMATIC APPROACH TO THE IDENTIFICATION, APPRAISAL, AND USE OF HEALTH STATE UTILITY VALUES FOR REIMBURSEMENT DECISION MAKING\", \"url\": \"https://experts.mcmaster.ca/display/publication1658796\", \"journal\": \"Value in Health\", \"year\": \"2019\", \"doi\": \"10.1016/j.jval.2019.04.166\"}, {\"title\": \"PNS88 IMPACT OF PATIENT-TARGETED FINANCIAL INCENTIVES ON HEALTHCARE COSTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS\", \"url\": \"https://experts.mcmaster.ca/display/publication1658882\", \"journal\": \"Value in Health\", \"year\": \"2019\", \"doi\": \"10.1016/j.jval.2019.04.1447\"}, {\"title\": \"A META-EPIDEMIOLOGICAL SURVEY OF THE REPORTING OF EFFECT MODIFICATION IN NETWORK META-ANALYSES\", \"url\": \"https://experts.mcmaster.ca/display/publication1342663\", \"journal\": \"Value in Health\", \"year\": \"2017\"}, {\"title\": \"The Efficacy and Safety of Biological Disease Modifying Anti-Rheumatic Drugs and Apremilast in the Treatment of Psoriatic Arthritis: A Systematic Review and Meta-Analysis\", \"url\": \"https://experts.mcmaster.ca/display/publication1367770\", \"journal\": \"Arthritis & Rheumatology\", \"year\": \"2014\"}], \"other\": [], \"preprints\": [{\"title\": \"Clinical Trial Data Sharing for COVID-19\\u2013Related Research (Preprint)\", \"url\": \"https://experts.mcmaster.ca/display/publication3245946\", \"year\": \"2020\", \"doi\": \"10.2196/preprints.26718\"}, {\"title\": \"Evaluation of effects of public health interventions on COVID-19 transmission for Pakistan: A mathematical simulation study\", \"url\": \"https://experts.mcmaster.ca/display/publication3245947\", \"year\": \"2020\", \"doi\": \"10.1101/2020.04.30.20086447\"}, {\"title\": \"Systematic review of basket trials, umbrella trials, and platform trials: A landscape analysis of master protocols\", \"url\": \"https://experts.mcmaster.ca/display/publication3245949\", \"year\": \"2019\", \"doi\": \"10.21203/rs.2.9437/v2\"}, {\"title\": \"Systematic review of basket trials, umbrella trials, and platform trials: A landscape analysis of master protocols\", \"url\": \"https://experts.mcmaster.ca/display/publication3245948\", \"year\": \"2019\", \"doi\": \"10.21203/rs.2.9437/v1\"}]}",
  "teaching_activities_json": "[]",
  "teaching_courses_count": 0,
  "coauthor_network_url": "https://experts.mcmaster.ca/vis/author-network/zorattmj",
  "science_map_url": "https://experts.mcmaster.ca/vis/map-of-science/zorattmj",
  "profile_url": "https://experts.mcmaster.ca/individual/zorattmj",
  "scraped_date": "2025-07-27T15:15:33.714172",
  "csv_name": "Michael  Zoratti",
  "csv_degree": "PhD",
  "csv_university": "McMaster University",
  "csv_faculty": "Faculty of Health Sciences",
  "csv_department": "Department of Health Research Methods, Evidence, and Impact (HEI)",
  "csv_other_depts": NaN,
  "csv_position": "Assistant Professor",
  "csv_full_time": true,
  "csv_faculty_type": "Faculty",
  "csv_adjunct": false,
  "csv_uni_email": "zorattmj@mcmaster.ca",
  "csv_other_email": NaN,
  "csv_website": NaN,
  "csv_misc": NaN,
  "csv_twitter": NaN,
  "csv_phone": NaN,
  "csv_fax": NaN,
  "csv_gscholar": NaN,
  "csv_scopus": NaN,
  "csv_wos": NaN,
  "csv_orcid": NaN,
  "csv_researchgate": NaN,
  "csv_academicedu": NaN,
  "csv_linkedin": NaN,
  "csv_mendely": NaN,
  "publications": {
    "journal_articles": [
      {
        "title": "Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel.",
        "url": "https://experts.mcmaster.ca/display/publication3534474",
        "journal": "Blood Advances",
        "year": "2025",
        "doi": "10.1182/bloodadvances.2024013656"
      },
      {
        "title": "Abstract 4991: Temporal trends in health-related quality of life (HRQoL) outcomes in fourth line or higher treatment for relapsed/refractory multiple myeloma (RRMM): A systematic literature review (SLR) and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication3587043",
        "journal": "Cancer Research",
        "year": "2025",
        "doi": "10.1158/1538-7445.am2025-4991"
      },
      {
        "title": "Health Related Quality of Life (HRQoL) in Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review (SLR) and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3505084",
        "journal": "Blood",
        "year": "2024",
        "doi": "10.1182/blood-2024-203741"
      },
      {
        "title": "Unmet needs in relapsed/refractory mantle cell lymphoma (r/r MCL) post-covalent Bruton tyrosine kinase inhibitor (BTKi): a systematic literature review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication3450503",
        "journal": "Leukemia and Lymphoma",
        "year": "2024",
        "doi": "10.1080/10428194.2024.2369653"
      },
      {
        "title": "MM-357 Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients",
        "url": "https://experts.mcmaster.ca/display/publication3494186",
        "journal": "Clinical Lymphoma, Myeloma and Leukemia",
        "year": "2024",
        "doi": "10.1016/s2152-2650(24)01670-7"
      },
      {
        "title": "P-063 Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients",
        "url": "https://experts.mcmaster.ca/display/publication3494184",
        "journal": "Clinical Lymphoma, Myeloma and Leukemia",
        "year": "2024",
        "doi": "10.1016/s2152-2650(24)01966-9"
      },
      {
        "title": "Systematic Literature Review and Meta-Analysis of Clinical Trials of Fourth Line or Higher Treatment for Relapsed/Refractory Multiple Myeloma Patients",
        "url": "https://experts.mcmaster.ca/display/publication3494185",
        "journal": "Clinical Lymphoma, Myeloma and Leukemia",
        "year": "2024",
        "doi": "10.1016/s2152-2650(24)00957-1"
      },
      {
        "title": "Cannabis for medical use versus opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomised clinical trials",
        "url": "https://experts.mcmaster.ca/display/publication3385438",
        "journal": "BMJ Open",
        "year": "2024",
        "doi": "10.1136/bmjopen-2022-068182"
      },
      {
        "title": "Cystoid macular edema prophylaxis in cataract surgery: A protocol for network meta-analysis.",
        "url": "https://experts.mcmaster.ca/display/publication3504795",
        "journal": "PLoS ONE",
        "year": "2024",
        "doi": "10.1371/journal.pone.0314467"
      },
      {
        "title": "EE688 Case for Clear Communication and Justification of Survival Extrapolation Methodology: A Review of NICE Submissions in Oncology",
        "url": "https://experts.mcmaster.ca/display/publication3494187",
        "journal": "Value in Health",
        "year": "2023",
        "doi": "10.1016/j.jval.2023.09.953"
      },
      {
        "title": "MSR15 The Impact of Response Assessment Timing on Indirect Treatment Comparisons (ITCS) – A Simulation Study",
        "url": "https://experts.mcmaster.ca/display/publication3494188",
        "journal": "Value in Health",
        "year": "2023",
        "doi": "10.1016/j.jval.2023.09.2074"
      },
      {
        "title": "MCL-373 Unmet Need in Relapsed/Refractory (RR) Mantle Cell Lymphoma (MCL) Post-Bruton Tyrosine Kinase Inhibitor (BTKi): Systematic Literature Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3494190",
        "journal": "Clinical Lymphoma, Myeloma and Leukemia",
        "year": "2023",
        "doi": "10.1016/s2152-2650(23)01377-0"
      },
      {
        "title": "POSTER: MCL-373 Unmet Need in Relapsed/Refractory (RR) Mantle Cell Lymphoma (MCL) Post-Bruton Tyrosine Kinase Inhibitor (BTKi): Systematic Literature Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3494189",
        "journal": "Clinical Lymphoma, Myeloma and Leukemia",
        "year": "2023",
        "doi": "10.1016/s2152-2650(23)00776-0"
      },
      {
        "title": "Theory and practice of Bayesian and frequentist frameworks for network meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication2315252",
        "journal": "BMJ Evidence-Based Medicine",
        "year": "2023",
        "doi": "10.1136/bmjebm-2022-111928"
      },
      {
        "title": "UNMET NEED IN RELAPSED/REFRACTORY (R/R) MANTLE CELL LYMPHOMA (MCL) POST‐BRUTON TYROSINE KINASE INHIBITOR (BTKI): A SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSIS",
        "url": "https://experts.mcmaster.ca/display/publication3494192",
        "journal": "Hematological Oncology",
        "year": "2023",
        "doi": "10.1002/hon.3165_603"
      },
      {
        "title": "Treatment outcomes for newly diagnosed, treatment-naïve TP53-mutated acute myeloid leukemia: a systematic review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication2980732",
        "journal": "Journal of Hematology and Oncology",
        "year": "2023",
        "doi": "10.1186/s13045-023-01417-5"
      },
      {
        "title": "Azacitidine Monotherapy in Patients With Treatment-Naïve Higher-risk Myelodysplastic Syndrome: A Systematic Literature Review and Meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication2658796",
        "journal": "Clinical Lymphoma, Myeloma and Leukemia",
        "year": "2023",
        "doi": "10.1016/j.clml.2022.11.002"
      },
      {
        "title": "Reverse Total Shoulder Arthroplasty Is the Most Cost-effective Treatment Strategy for Proximal Humerus Fractures in Older Adults: A Cost-utility Analysis",
        "url": "https://experts.mcmaster.ca/display/publication2433833",
        "journal": "Clinical Orthopaedics and Related Research",
        "year": "2022",
        "doi": "10.1097/corr.0000000000002219"
      },
      {
        "title": "Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naïve, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.",
        "url": "https://experts.mcmaster.ca/display/publication3245942",
        "journal": "Journal of Clinical Oncology",
        "year": "2022",
        "doi": "10.1200/jco.2022.40.16_suppl.e19062"
      },
      {
        "title": "Treatment outcomes for newly diagnosed, untreatedTP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.",
        "url": "https://experts.mcmaster.ca/display/publication3245943",
        "journal": "Journal of Clinical Oncology",
        "year": "2022",
        "doi": "10.1200/jco.2022.40.16_suppl.e19020"
      },
      {
        "title": "POSC427 Platform Trials: A Path to Efficient Decision Making and Faster Drug Approvals for Health Technology Assessment Bodies",
        "url": "https://experts.mcmaster.ca/display/publication3245944",
        "journal": "Value in Health",
        "year": "2022",
        "doi": "10.1016/j.jval.2021.11.1346"
      },
      {
        "title": "Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART",
        "url": "https://experts.mcmaster.ca/display/publication1965105",
        "journal": "BMC Medical Research Methodology",
        "year": "2021",
        "doi": "10.1186/s12874-021-01254-5"
      },
      {
        "title": "Towards Transparency in the Selection of Published Health Utility Inputs in Cost-Utility Analyses: The Health Utility Application Tool (HAT)",
        "url": "https://experts.mcmaster.ca/display/publication1983995",
        "journal": "PharmacoEconomics (Auckland)",
        "year": "2021",
        "doi": "10.1007/s40273-021-01039-0"
      },
      {
        "title": "Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists",
        "url": "https://experts.mcmaster.ca/display/publication1966330",
        "journal": "European Journal of Health Economics",
        "year": "2021",
        "doi": "10.1007/s10198-021-01286-0"
      },
      {
        "title": "Clinical Trial Data Sharing for COVID-19–Related Research",
        "url": "https://experts.mcmaster.ca/display/publication1963558",
        "journal": "Journal of Medical Internet Research",
        "year": "2021",
        "doi": "10.2196/26718"
      },
      {
        "title": "Heterogeneity in renal end points of cardiovascular outcomes trials in Type 2 diabetes",
        "url": "https://experts.mcmaster.ca/display/publication2658699",
        "journal": "Journal of Comparative Effectiveness Research",
        "year": "2021",
        "doi": "10.2217/cer-2020-0137"
      },
      {
        "title": "Reporting and design of randomized controlled trials for COVID-19: A systematic review",
        "url": "https://experts.mcmaster.ca/display/publication1940270",
        "journal": "Contemporary Clinical Trials",
        "year": "2021",
        "doi": "10.1016/j.cct.2020.106239"
      },
      {
        "title": "Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents",
        "url": "https://experts.mcmaster.ca/display/publication1941464",
        "journal": "Journal of the Endocrine Society",
        "year": "2021",
        "doi": "10.1210/jendso/bvaa155"
      },
      {
        "title": "Comparative efficacy, tolerability and safety of dolutegravir and efavirenz 400mg among antiretroviral therapies for first-line HIV treatment: A systematic literature review and network meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1939396",
        "journal": "EClinicalMedicine",
        "year": "2020",
        "doi": "10.1016/j.eclinm.2020.100573"
      },
      {
        "title": "Conservative Intervention Strategies for Adult Cancer-Related Lymphedema: A Systematic Review and Network Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1923169",
        "journal": "Oncology Nursing Forum",
        "year": "2020",
        "doi": "10.1188/20.onf.e171-e189"
      },
      {
        "title": "PNS18 IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT)",
        "url": "https://experts.mcmaster.ca/display/publication2579408",
        "journal": "Value in Health",
        "year": "2020",
        "doi": "10.1016/j.jval.2020.04.1029"
      },
      {
        "title": "An Exploratory Analysis of Predictors of Concordance Between Canadian Common Drug Review Reimbursement Recommendations and the Subsequent Decisions by Ontario, British Columbia and Alberta",
        "url": "https://experts.mcmaster.ca/display/publication1698147",
        "journal": "Healthcare Policy",
        "year": "2020",
        "doi": "10.12927/hcpol.2020.26128"
      },
      {
        "title": "Pangenotypic direct acting antivirals for the treatment of chronic hepatitis C virus infection: A systematic literature review and meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1688096",
        "journal": "EClinicalMedicine",
        "year": "2020",
        "doi": "10.1016/j.eclinm.2019.12.007"
      },
      {
        "title": "The Landscape of Emerging Randomized Clinical Trial Evidence for COVID-19 Disease Stages: A Systematic Review of Global Trial Registries",
        "url": "https://experts.mcmaster.ca/display/publication1943576",
        "journal": "Infection and Drug Resistance",
        "year": "2020",
        "doi": "10.2147/idr.s288399"
      },
      {
        "title": "Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols",
        "url": "https://experts.mcmaster.ca/display/publication1665447",
        "journal": "Trials",
        "year": "2019",
        "doi": "10.1186/s13063-019-3664-1"
      },
      {
        "title": "PDB3 HETEROGENEITY IN RENAL COMPOSITE ENDPOINTS IN CARDIOVASCULAR OUTCOMES TRIALS IN TYPE 2 DIABETES (T2D)",
        "url": "https://experts.mcmaster.ca/display/publication3245950",
        "journal": "Value in Health",
        "year": "2019",
        "doi": "10.1016/j.jval.2019.09.885"
      },
      {
        "title": "PNS278 A REVIEW OF HEALTH TECHNOLOGY ASSESSMENT GUIDELINES ON THE APPROVAL OF BIOSIMILARS",
        "url": "https://experts.mcmaster.ca/display/publication3245951",
        "journal": "Value in Health",
        "year": "2019",
        "doi": "10.1016/j.jval.2019.09.2178"
      },
      {
        "title": "Reporting of master protocols towards a standardized approach: A systematic review",
        "url": "https://experts.mcmaster.ca/display/publication1654087",
        "journal": "Contemporary Clinical Trials Communications",
        "year": "2019",
        "doi": "10.1016/j.conctc.2019.100406"
      },
      {
        "title": "A Profile of Older Adults With a History of Stroke Receiving Home Care in Ontario, Canada",
        "url": "https://experts.mcmaster.ca/display/publication1697803",
        "journal": "Home Health Care Management and Practice",
        "year": "2019",
        "doi": "10.1177/1084822318823731"
      },
      {
        "title": "Health Utility Book (HUB)–Cancer: Protocol for a Systematic Literature Review of Health State Utility Values in Cancer",
        "url": "https://experts.mcmaster.ca/display/publication1663230",
        "journal": "MDM Policy and Practice",
        "year": "2019",
        "doi": "10.1177/2381468319852594"
      },
      {
        "title": "Ezetimibe in high-risk, previously treated statin patients: a systematic review and network meta-analysis of lipid efficacy",
        "url": "https://experts.mcmaster.ca/display/publication3245952",
        "journal": "Clinical Research in Cardiology",
        "year": "2019",
        "doi": "10.1007/s00392-018-1379-z"
      },
      {
        "title": "Toward a Centralized, Systematic Approach to the Identification, Appraisal, and Use of Health State Utility Values for Reimbursement Decision Making: Introducing the Health Utility Book (HUB)",
        "url": "https://experts.mcmaster.ca/display/publication1634805",
        "journal": "Medical decision making",
        "year": "2019",
        "doi": "10.1177/0272989x19837969"
      },
      {
        "title": "How do financial (dis)incentives influence health behaviour and costs? Protocol for a systematic literature review of randomised controlled trials",
        "url": "https://experts.mcmaster.ca/display/publication1639835",
        "journal": "BMJ Open",
        "year": "2019",
        "doi": "10.1136/bmjopen-2018-024694"
      },
      {
        "title": "Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma",
        "url": "https://experts.mcmaster.ca/display/publication1630075",
        "journal": "Cancer Treatment Reviews",
        "year": "2019",
        "doi": "10.1016/j.ctrv.2019.02.001"
      },
      {
        "title": "Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication1936699",
        "journal": "Gates Open Research",
        "year": "2019",
        "doi": "10.12688/gatesopenres.13081.2"
      },
      {
        "title": "Change in Prolactin Levels in Pediatric Patients Given Antipsychotics for Schizophrenia and Schizophrenia Spectrum Disorders: A Network Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1545901",
        "journal": "Schizophrenia Research and Treatment",
        "year": "2018",
        "doi": "10.1155/2018/1543034"
      },
      {
        "title": "Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey",
        "url": "https://experts.mcmaster.ca/display/publication829123",
        "journal": "Journal of Clinical Epidemiology",
        "year": "2017",
        "doi": "10.1016/j.jclinepi.2017.06.004"
      },
      {
        "title": "Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication3245953",
        "journal": "Diabetes Therapy",
        "year": "2017",
        "doi": "10.1007/s13300-016-0217-4"
      },
      {
        "title": "Prolactin-related adverse events and change in prolactin levels in pediatric patients given antipsychotics for schizophrenia and schizophrenia spectrum disorders: A systematic review",
        "url": "https://experts.mcmaster.ca/display/publication794752",
        "journal": "BMC Pediatrics",
        "year": "2016",
        "doi": "10.1186/s12887-016-0710-y"
      },
      {
        "title": "What Is the Link Between Corporal Punishment and Child Physical Abuse?",
        "url": "https://experts.mcmaster.ca/display/publication2658700",
        "journal": "Journal of Family Violence",
        "year": "2015",
        "doi": "10.1007/s10896-014-9663-9"
      },
      {
        "title": "Highlights of the Canadian Frailty Network (CFN) Highly Qualified Personnel Poster Session",
        "url": "https://experts.mcmaster.ca/display/publication1972012",
        "journal": "Canadian Geriatrics Journal",
        "doi": "10.57700/cgj.22.369"
      },
      {
        "title": "Interventions to improve birth outcomes of pregnant women living in low- and middle-income countries: a systematic review and network meta-analysis",
        "url": "https://experts.mcmaster.ca/display/publication3245945",
        "journal": "Gates Open Research",
        "doi": "10.12688/gatesopenres.13081.1"
      },
      {
        "title": "P1204: AXICABTAGENE CILOLEUCEL VEIN‐TO‐VEIN TIME IN TRIAL OR REAL‐WORLD SETTINGS VS OTHER CAR T‐CELL THERAPIES FOR RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA: A SYSTEMATIC LITERATURE REVIEW AND META‐ANALYSIS",
        "url": "https://experts.mcmaster.ca/display/publication3494191",
        "journal": "HemaSphere",
        "doi": "10.1097/01.hs9.0000971712.73401.70"
      },
      {
        "title": "P552: TREATMENT OUTCOMES IN NEWLY DIAGNOSED, UNTREATED PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS",
        "url": "https://experts.mcmaster.ca/display/publication3245941",
        "journal": "HemaSphere",
        "doi": "10.1097/01.hs9.0000845096.01949.78"
      },
      {
        "title": "P774: CLINICAL OUTCOMES ASSOCIATED WITH AZACITIDINE MONOTHERAPY FOR TREATMENT-NAIVE PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROME (HR MDS): A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS",
        "url": "https://experts.mcmaster.ca/display/publication3245940",
        "journal": "HemaSphere",
        "doi": "10.1097/01.hs9.0000845980.88839.7d"
      }
    ],
    "chapters": [],
    "conferences": [
      {
        "title": "Clinical outcomes associated with azacitidine (AZA) monotherapy for treatment-naive, higher-risk myelodysplastic syndrome (HR-MDS): A systematic literature review and meta-analysis.",
        "url": "https://experts.mcmaster.ca/display/publication2472487",
        "journal": "Journal of Clinical Oncology",
        "year": "2022"
      },
      {
        "title": "Treatment outcomes for newly diagnosed, untreatedTP53-mutated acute myeloid leukemia: A systematic review and meta-analysis.",
        "url": "https://experts.mcmaster.ca/display/publication2472488",
        "journal": "Journal of Clinical Oncology",
        "year": "2022"
      },
      {
        "title": "IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT)",
        "url": "https://experts.mcmaster.ca/display/publication1914423",
        "journal": "Value in Health",
        "year": "2020"
      },
      {
        "title": "PCN41 THE HEALTH UTILITY BOOK (HUB): A REGISTRY OF HEALTH STATE UTILITY VALUES IN ONCOLOGY",
        "url": "https://experts.mcmaster.ca/display/publication1658797",
        "journal": "Value in Health",
        "year": "2019",
        "doi": "10.1016/j.jval.2019.04.165"
      },
      {
        "title": "PCN42 THE HEALTH UTILITY BOOK (HUB): TOWARD A CENTRALIZED, SYSTEMATIC APPROACH TO THE IDENTIFICATION, APPRAISAL, AND USE OF HEALTH STATE UTILITY VALUES FOR REIMBURSEMENT DECISION MAKING",
        "url": "https://experts.mcmaster.ca/display/publication1658796",
        "journal": "Value in Health",
        "year": "2019",
        "doi": "10.1016/j.jval.2019.04.166"
      },
      {
        "title": "PNS88 IMPACT OF PATIENT-TARGETED FINANCIAL INCENTIVES ON HEALTHCARE COSTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS",
        "url": "https://experts.mcmaster.ca/display/publication1658882",
        "journal": "Value in Health",
        "year": "2019",
        "doi": "10.1016/j.jval.2019.04.1447"
      },
      {
        "title": "A META-EPIDEMIOLOGICAL SURVEY OF THE REPORTING OF EFFECT MODIFICATION IN NETWORK META-ANALYSES",
        "url": "https://experts.mcmaster.ca/display/publication1342663",
        "journal": "Value in Health",
        "year": "2017"
      },
      {
        "title": "The Efficacy and Safety of Biological Disease Modifying Anti-Rheumatic Drugs and Apremilast in the Treatment of Psoriatic Arthritis: A Systematic Review and Meta-Analysis",
        "url": "https://experts.mcmaster.ca/display/publication1367770",
        "journal": "Arthritis & Rheumatology",
        "year": "2014"
      }
    ],
    "other": [],
    "preprints": [
      {
        "title": "Clinical Trial Data Sharing for COVID-19–Related Research (Preprint)",
        "url": "https://experts.mcmaster.ca/display/publication3245946",
        "year": "2020",
        "doi": "10.2196/preprints.26718"
      },
      {
        "title": "Evaluation of effects of public health interventions on COVID-19 transmission for Pakistan: A mathematical simulation study",
        "url": "https://experts.mcmaster.ca/display/publication3245947",
        "year": "2020",
        "doi": "10.1101/2020.04.30.20086447"
      },
      {
        "title": "Systematic review of basket trials, umbrella trials, and platform trials: A landscape analysis of master protocols",
        "url": "https://experts.mcmaster.ca/display/publication3245949",
        "year": "2019",
        "doi": "10.21203/rs.2.9437/v2"
      },
      {
        "title": "Systematic review of basket trials, umbrella trials, and platform trials: A landscape analysis of master protocols",
        "url": "https://experts.mcmaster.ca/display/publication3245948",
        "year": "2019",
        "doi": "10.21203/rs.2.9437/v1"
      }
    ]
  },
  "filename": "Michael_Zoratti.json",
  "file_created": "2025-07-27T15:15:33.714727"
}